Spectrofluorimetric quantitative analysis of favipiravir, remdesivir and hydroxychloroquine in spiked human plasma

In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Xueting Yao, Fei Ye, Miao Zhang et al. · Clinical Infectious Diseases · 2020 · 2.8K citations · Full text

Medicine, Infectious Diseases, Pharmacology +17

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19

Jason D. Goldman, David Chien Lye, David S.C. Hui et al. · New England Journal of Medicine · 2020 · 1.4K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study

Qingxian Cai, Minghui Yang, Dongjing Liu et al. · Engineering · 2020 · 1.4K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2

Brandi N. Williamson, Friederike Feldmann, Benjamin Schwarz et al. · Nature · 2020 · 740 citations · Full text

Life Sciences, Immunology, Infectious Diseases +14

Multicomponent analysis by synchronous luminescence spectrometry

Tuan Vo‐Dinh · Analytical Chemistry · 1978 · 452 citations

Natural Sciences, Chemistry, Analytical Chemistry +6